Article Versions Notes

Levartovsky A, Cohen I, Abitbol CM, Yavzori M, Fudim E, Picard O, Kopylov U, Ben-Horin S, Ungar B. Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease? Biomedicines. 2023; 11(6):1553. https://doi.org/10.3390/biomedicines11061553

Levartovsky, Asaf, Ido Cohen, Chaya Mushka Abitbol, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Shomron Ben-Horin, and Bella Ungar. 2023. "Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?" Biomedicines 11, no. 6: 1553. https://doi.org/10.3390/biomedicines11061553

Levartovsky, A., Cohen, I., Abitbol, C. M., Yavzori, M., Fudim, E., Picard, O., Kopylov, U., Ben-Horin, S., & Ungar, B. (2023). Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease? Biomedicines, 11(6), 1553. https://doi.org/10.3390/biomedicines11061553